Affinity and Epitope Profiling of Mouse Anti-CD40 Monoclonal Antibodies
(2003) In Scandinavian Journal of Immunology 57(6). p.517-524- Abstract
- The CD40-CD40L interaction plays a critical role in both humoral and cellular immune responses and interfering antibodies have been suggested as an effective approach for the treatment of lymphomas and autoimmune diseases. In this study we have profiled a panel of mouse antihuman CD40 monoclonal antibodies (MoAbs), regarding their CD40 binding affinity and epitope-specificity relative to the CD40L binding in relation to their cellular activating potential. Despite a rather similar domain-recognition profile, the MoAbs blocked the CD40L binding to a varying degree, with MoAb 5C3 being the poorest inhibitor. There was no correlation between affinity and cellular activation potential. In contrast, a correlation between the ability to block... (More)
- The CD40-CD40L interaction plays a critical role in both humoral and cellular immune responses and interfering antibodies have been suggested as an effective approach for the treatment of lymphomas and autoimmune diseases. In this study we have profiled a panel of mouse antihuman CD40 monoclonal antibodies (MoAbs), regarding their CD40 binding affinity and epitope-specificity relative to the CD40L binding in relation to their cellular activating potential. Despite a rather similar domain-recognition profile, the MoAbs blocked the CD40L binding to a varying degree, with MoAb 5C3 being the poorest inhibitor. There was no correlation between affinity and cellular activation potential. In contrast, a correlation between the ability to block CD40L-binding and activation potential could be seen. We believe that this analysis of several mouse anti-CD40 antibodies can be used to develop strategies for producing new human anti-CD40 antibodies that can more effectively induce or block B-cell proliferation. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/134310
- author
- Malmborg Hager, Ann-Christin LU ; Ellmark, Peter LU ; Borrebaeck, Carl LU and Furebring, Christina LU
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Scandinavian Journal of Immunology
- volume
- 57
- issue
- 6
- pages
- 517 - 524
- publisher
- Wiley-Blackwell
- external identifiers
-
- wos:000183367900003
- pmid:12791089
- scopus:0038040565
- ISSN
- 1365-3083
- DOI
- 10.1046/j.1365-3083.2003.01271.x
- language
- English
- LU publication?
- yes
- id
- 4c6c4f5d-06e0-43e8-96d6-6944b4c5c749 (old id 134310)
- date added to LUP
- 2016-04-01 17:13:36
- date last changed
- 2022-01-29 01:17:06
@article{4c6c4f5d-06e0-43e8-96d6-6944b4c5c749, abstract = {{The CD40-CD40L interaction plays a critical role in both humoral and cellular immune responses and interfering antibodies have been suggested as an effective approach for the treatment of lymphomas and autoimmune diseases. In this study we have profiled a panel of mouse antihuman CD40 monoclonal antibodies (MoAbs), regarding their CD40 binding affinity and epitope-specificity relative to the CD40L binding in relation to their cellular activating potential. Despite a rather similar domain-recognition profile, the MoAbs blocked the CD40L binding to a varying degree, with MoAb 5C3 being the poorest inhibitor. There was no correlation between affinity and cellular activation potential. In contrast, a correlation between the ability to block CD40L-binding and activation potential could be seen. We believe that this analysis of several mouse anti-CD40 antibodies can be used to develop strategies for producing new human anti-CD40 antibodies that can more effectively induce or block B-cell proliferation.}}, author = {{Malmborg Hager, Ann-Christin and Ellmark, Peter and Borrebaeck, Carl and Furebring, Christina}}, issn = {{1365-3083}}, language = {{eng}}, number = {{6}}, pages = {{517--524}}, publisher = {{Wiley-Blackwell}}, series = {{Scandinavian Journal of Immunology}}, title = {{Affinity and Epitope Profiling of Mouse Anti-CD40 Monoclonal Antibodies}}, url = {{https://lup.lub.lu.se/search/files/4913606/624423.pdf}}, doi = {{10.1046/j.1365-3083.2003.01271.x}}, volume = {{57}}, year = {{2003}}, }